Clinical and basic scientific investigation of spinal muscular atrophy towards the elucidation of disease mechanism and the development of therapy
Clinical and basic scientific investigation of spinal muscular atrophy towards the elucidation of disease mechanism and the development of therapy
批准号:
12470173
负责人:
SAITO Kayoko
金额:
$8.58万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2003
中文摘要
脊髓性肌萎缩症(SMA)是一种常染色体隐性遗传病,分为三种类型。SMN(存活型运动神经元)基因是SMA的决定基因,命名为SMNt和SMNC。虽然SMA的病因被认为是SMNt缺失,但三种类型的临床症状严重程度不同,表现为SMNt缺失。为了阐明临床变异的基础,我们对29例日本SMA患者的SMN基因的DNA和mRNA进行了分析。一种大的基因缺失,包括SMN和其他在重症临床类型中被识别的基因。我们检测到一个杂交基因,即从SMNt到SMNC的基因转化产物。我们还对克隆的SMN外显子6、7和8进行了序列分析,获得了1例SMN外显子7的端粒序列。提示该患者可能发生了以SMNt取代SMNC的序列转换。综上所述,SMNt和修饰基因的缺失使表型更加严重,而部分基因转换事件是导致表型较温和的原因。
英文摘要
Spinal muscular atrophy (SMA) is an autosomal recessive disorder, classified into three types. The SMN (survival motor neuron) gene has been identified as a SMA-determining gene, designated SMNt and SMNc. Although the etiology of SMA is regarded as deletion of SMNt, the severity of clinical symptom is different among three types, and they show the same deletion of SMNt. In order to elucidate the basis of clinical variation, we analyzed the DNA and mRNA of the SMN gene in the Japanese 29 SMA patients. A large gene deletion including SMN and other genes as recognized in severe clinical type. We detected a hybrid gene, the products of gene conversion from SMNt to SMNc. Hybrid genes were found by a total nine patients, only in type II and III. We also performed sequence analysis of the cloned RT-PCR products of SMN exons 6,7 and 8. We obtained telomeric sequence of exon 7 of one patient. It suggests that sequence conversion replacing SMNc with SMNt may have occurred at mRNA level in this patient. In conclusion, deletion of the SMNt and the modifier genes made the phenotype more severe, and partial gene conversion event was the explanation for the milder phenotype.
期刊论文(72)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
斎藤 加代子: "神経筋疾患-疾患原因遺伝子の解明"医学のあゆみ「小児医療の最前線」. 206・9. 555-559 (2003)
齐藤加代子:“神经肌肉疾病 - 致病基因的阐明”医学史“儿科医学的前沿”206・9(2003)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
斎藤 加代子(監修): "SMA(脊髄性筋萎縮症)ってなに?"SMA(脊髄性筋萎縮症)家族の会発行. 79 (2002)
Kayoko Saito(监督):“什么是 SMA(脊髓性肌肉萎缩症)?” SMA(脊髓性肌肉萎缩症)家族协会出版 79(2002 年)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Saito K.: "Clinical and molecular genetic characteristics of spinal musucular atrophy"Development in Pediatric Neurology. (in press). (2004)
Saito K.:“脊髓性肌萎缩症的临床和分子遗传学特征”小儿神经病学的发展。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
斎藤 加代子: "胎生期に発生した疾患の遺伝カウンセリングと予後.中枢神経・筋"周産期医学. 33. 1097-1101 (2003)
Kayoko Saito:“胎儿期疾病的遗传咨询和预后。中枢神经系统和肌肉”围产期医学。33。1097-1101(2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
斎藤 加代子: "脊髄性筋萎縮症"日本臨牀 領域別症候群シリーズNo.34先天異常症候群辞典. 下巻. 672-674 (2001)
Kayoko Saito:《脊髓性肌肉萎缩症》日本临床研究领域综合症系列第 34 期先天性异常综合症词典第 2 卷。672-674(2001 年)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 28 条
Clinical, Epidemiological and Molecular Genetical Research for Spinal Muscular Atrophy
-
批准号:10670762
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:1998
-
负责人:SAITO Kayoko
-
依托单位:
Clinical and basic scientific researchi toward gene therapy in progressive muscular dystrophies
-
批准号:07670906
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.6万
-
财政年份:1995
-
负责人:SAITO Kayoko
-
依托单位: